Rochester,NY 8/28/2009 9:19:29 PM
Pfizer Inc. PFE, Abbott Laboratories to Collaborate With Pfizer for lung cancer screening
Pfizer Inc.
Abbott Laboratories and Pfizer Inc said on Thursday they were teaming up to match a genetic test for lung cancer with a new type of drug to treat it. The idea is to focus the treatment on patients most likely to benefit.
Abbott Molecular, a unit of Abbott Labs that makes genetic and other medical tests, said it would develop a test that determines a patient's genetic status.
Results would be used to select patients for future clinical trials of a new oral cancer therapy, known as PF-02341066, being developed by Pfizer, the world's largest drugmaker.
About Stock EinsteinStockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
